论文部分内容阅读
The high incidence of cancer and high mortality force humans extreme desire for effective treatment of cancer.
Tumor Therapy Study on Cinnamaldehyde Derivatives of Ir(Ⅲ)Polypyridyl Complexes
【摘 要】
：
The high incidence of cancer and high mortality force humans extreme desire for effective treatment of cancer.
【机 构】
：
School of Pharmacy,Guangdong Pharmaceutical University,Guangzhou,510006
【出 处】
：
第十一届全国化学生物学学术会议
【发表日期】
：
2019年3期
其他文献
Multifunctional Gold Nanoparticles as Smart Nanovehicles with Enhanced Tumour-Targeting Abilities fo
A number of multimodal agents have been developed for tumour imaging and diagnosing,however,most of them cannot be used to study the detailed physiological or pathological changes in living cells at t
FTO,the first m6A demethylases,has been reported to regulate tumorigenesis of glioblastoma stem cells [1] and melanoma [2].
新型人工金属蛋白扩展了天然蛋白催化应用领域，在近些年引起研究者的兴趣[1]，其中在我们前期设计的人工金属蛋白中L29E Mb 蛋白表现出了较好的水解活性，并且我们以ZnPP 为金属辅基构建了系列具有光调控核酸酶活性的人工金属蛋白[2]。
顺铂作为一线化疗药物对多种肿瘤有治疗效果，但因其存在的毒副作用和耐药性等缺陷，严重限制了其临床应用。四价铂前药以其良好的稳定性、较好的脂溶性和较低的毒性等优势，可有效克服铂类药物的缺陷。
肺动脉高压(Pulmonary Arterial Hypertension,PAH)是一类快速进展且病情严重的肺血管疾病,被称为“心血管中癌症”.NO 在心肺血管系统中具有舒张血管、降低血压、抑制血管平滑肌增殖、影响血管重构和血小板粘附等重要生理作用,因而在高血压、心肌缺血、肺动脉高压等心肺血管疾病的发病中具有重要意义.
In our previous work,we have designed and synthesized a series of dibenzoxanthenes(Figure.1)which showed antitumor activity.
PCA(Protein-fragment complementation assays,蛋白质片段互补)实验结合荧光蛋白和荧光素酶等报告系统,被广泛地用于细胞内蛋白互作检测以及药物研发等.Ingrid Remy等人报道[1],将Gaussia 荧光素酶(GLuc)分成N 片段和C 片段后分别与互作蛋白融合,可以重构GLuc 对其底物CTZ(coelenterazine,腔肠素)的催化功能.
A series of novel metal iridium complexes containing phenanthroline derivatives were designed and synthesized by changing the substituent groups on the phenanthroline derivatives [1].
Design,Synthesis,and Anticancer Effect Studies of Iridium(Ⅲ)Polypyridyl Complexes against HeLa Cells
An iridium(Ⅲ)complex([Ir(PTTP)2(ppy)](PF6)(Ir-1)were synthesized and characterized.The cytotoxicity of Ir-1 against cancer cell lines SGC-7901,A549,HeLa,HepG2 and BEL-7402 was investigated using the M